| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/03/2011 | US20110053850 Doc1 compositions and methods for treating cancer |
| 03/03/2011 | US20110053848 Prodrug comprising a drug linker conjugate |
| 03/03/2011 | US20110053847 Methods of treating vasodilatory shock |
| 03/03/2011 | US20110053845 Localized vaginal delivery without detrimental blood levels |
| 03/03/2011 | US20110053841 N-terminal fgf variants having increased receptor selectivity and uses thereof |
| 03/03/2011 | US20110053840 Allele and isotope-specific intervention on mhc class ii molecules associated with autoimmune diseases by means of peptides |
| 03/03/2011 | US20110053240 Dna damaging agents in combination with tyrosine kinase inhibitors |
| 03/03/2011 | US20110053113 Implant and method for the manufacture thereof |
| 03/03/2011 | US20110052740 Skin Circulation-Improving Agent And Skin Temperature-Elevating Agent |
| 03/03/2011 | US20110052738 Topical pain formulation |
| 03/03/2011 | US20110052736 Methods and materials for reducing or eliminating risk factors associated with syndrome x |
| 03/03/2011 | US20110052732 Mineral absorption accelerator and iron deficiency anemia improver of food composition |
| 03/03/2011 | US20110052730 Leaves Extract of Panax sp., a Process of Making the Same and Uses Thereof |
| 03/03/2011 | US20110052729 Pharmaceutical or nutraceutical composition |
| 03/03/2011 | US20110052727 Anti Influenza Nutritional Supplements |
| 03/03/2011 | US20110052723 Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy |
| 03/03/2011 | US20110052722 Toleration Iron Supplement Compositions |
| 03/03/2011 | US20110052715 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof |
| 03/03/2011 | US20110052713 Repairing damaged nervous system tissue with nanoparticles |
| 03/03/2011 | US20110052712 Sprayable Polymers As Adhesion Barriers |
| 03/03/2011 | US20110052710 Novel nanoparticles for delivery of active agents |
| 03/03/2011 | US20110052709 Novel nanoparticles for delivery of active agents |
| 03/03/2011 | US20110052708 Methods and formulations for the delivery of pharmacologically active agents |
| 03/03/2011 | US20110052707 Combination of vitamin d and 25-hydroxyvitamin d 3 |
| 03/03/2011 | US20110052704 Tocotrienol compositions |
| 03/03/2011 | US20110052703 Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents |
| 03/03/2011 | US20110052702 Method and Apparatus for Producing Organic Nanotubes |
| 03/03/2011 | US20110052701 Particulates of a crth2 antagonist |
| 03/03/2011 | US20110052700 Gastric retentive pharmaceutical compositions for immediate and extended release of levosulpiride |
| 03/03/2011 | US20110052699 Drug delivery system with stabilising effect |
| 03/03/2011 | US20110052697 Aptamer-Directed Drug Delivery |
| 03/03/2011 | US20110052695 Drug delivery platforms comprising silk fibroin hydrogels and uses thereof |
| 03/03/2011 | US20110052694 Use of cannabidiol prodrugs in topical and transdermal administration with microneedles |
| 03/03/2011 | US20110052691 Sustained Release Systems and Preparation Method Thereof |
| 03/03/2011 | US20110052689 Sustained release of guaifenesin |
| 03/03/2011 | US20110052688 Solid dispersion composition |
| 03/03/2011 | US20110052687 Extended release pharmaceutical composition of paliperidone |
| 03/03/2011 | US20110052686 Modified release lamotrigine tablets |
| 03/03/2011 | US20110052685 Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen |
| 03/03/2011 | US20110052684 Pharmaceutical composition |
| 03/03/2011 | US20110052683 Pharmaceutical preparation for treating cardiovascular disease |
| 03/03/2011 | US20110052682 Methods for enhancing the release and absorption of water insoluble active agents |
| 03/03/2011 | US20110052681 Pharmaceutical compositions of entacapone co-micronized with sugar alcohols |
| 03/03/2011 | US20110052680 Encapsulation of oxidatively unstable compounds |
| 03/03/2011 | US20110052679 Solid naproxen concentrates and related dosage forms |
| 03/03/2011 | US20110052677 Modulation of srpx2-mediated angiogenesis |
| 03/03/2011 | US20110052674 Angiotensin ii receptor blocker derivatives |
| 03/03/2011 | US20110052669 Methods for modulating de novo hepatic lipogenesis by modulating xbp-1 activity |
| 03/03/2011 | US20110052667 Compositions and methods for inhibiting angiogenesis and tumorigenesis |
| 03/03/2011 | US20110052666 Compositions, Methods, and Systems for SIRNA Delivery |
| 03/03/2011 | US20110052665 Haemostatic material |
| 03/03/2011 | US20110052664 Antimicrobial Medical Dressings and Protecting Wounds and Catheter Sites |
| 03/03/2011 | US20110052663 Hemostatic Sponge with Enzyme and Method of Manufacture |
| 03/03/2011 | US20110052661 Pet dental hygiene product |
| 03/03/2011 | US20110052659 Implants for administering substances and methods of producing implants |
| 03/03/2011 | US20110052657 Implants for administering substances and methods of producing implants |
| 03/03/2011 | US20110052656 Method for controlling microbial biofilm in aqueous systems |
| 03/03/2011 | US20110052651 Antimicrobial compositions and products |
| 03/03/2011 | US20110052648 Oral modified-release formulations containing thiazepines |
| 03/03/2011 | US20110052647 Antidepressant Oral Pharmaceutical Compositions |
| 03/03/2011 | US20110052645 Manufacture of multiple minicapsules |
| 03/03/2011 | US20110052643 Compounds for inflammation and immune-related uses |
| 03/03/2011 | US20110052641 Halogenated aliphatic carboxylic acids, oligomers and/or polymers thereof and their use in devitalizing external and internal neoplasms |
| 03/03/2011 | US20110052640 Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies |
| 03/03/2011 | US20110052637 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as vaccines |
| 03/03/2011 | US20110052616 Biological materials and uses thereof |
| 03/03/2011 | US20110052613 Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase |
| 03/03/2011 | US20110052612 Spiropiperidine compound and medicinal use thereof |
| 03/03/2011 | US20110052603 method of treatment and agents useful for same |
| 03/03/2011 | US20110052602 Diagnosis and Treatment of Age Related Macular Degeneration |
| 03/03/2011 | US20110052599 Facilitation of Oocyte, Zygote and Pre-Implantation Embryo Maturation |
| 03/03/2011 | US20110052593 Breast cancer associated antigen |
| 03/03/2011 | US20110052589 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 03/03/2011 | US20110052588 Method of treating hepatocellular carcinoma |
| 03/03/2011 | US20110052585 Compositions and methods for inhibiting interleukin pathways |
| 03/03/2011 | US20110052583 Pyridinone compounds |
| 03/03/2011 | US20110052578 Compounds and Compositions as Protein Kinase Inhibitors |
| 03/03/2011 | US20110052576 Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors |
| 03/03/2011 | US20110052570 Method to prognose response to anti-egfr therapeutics |
| 03/03/2011 | US20110052569 Molecules and methods for treatment of diabetes |
| 03/03/2011 | US20110052567 Methods Compositions, Uses, and Kits Useful for Vitamin D Deficiency and Related Disorders |
| 03/03/2011 | US20110052566 Cognitive function |
| 03/03/2011 | US20110052563 Gonadal function improving agents |
| 03/03/2011 | US20110052562 Benzimidazoles and analogs as rho kinase inhibitors |
| 03/03/2011 | US20110052558 Materials and methods for prevention and treatment of rna viral diseases |
| 03/03/2011 | US20110052556 Pharmaceutical composition comprising racetam and carnitine and process for its preparation |
| 03/03/2011 | US20110052552 Compositions to effect neuronal growth |
| 03/03/2011 | US20110052536 Methods of treating a flaviviridae family viral infection and compositions for treating a flaviviridae family viral infection |
| 03/03/2011 | US20110052534 Imidazopyridazine Compounds for Treating Viral Infections |
| 03/03/2011 | US20110052531 Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy |
| 03/03/2011 | US20110052528 Neuroprotective macrocyclic compounds and methods for their use |
| 03/03/2011 | US20110052527 Imidazopyridinyl thiazolyl histone deacetylase inhibitors |
| 03/03/2011 | US20110052524 vertebroplasty method using an addition curable polysiloxane system |
| 03/03/2011 | US20110052515 Avermectin/benzoyl peroxide compositions for treating affliction of the skin, e.g., rosacea |
| 03/03/2011 | US20110052513 Cationic surfactant compounds, use thereof as conditioner, cosmetic treatment method, and cosmetic or pharmaceutical compositions comprising same |
| 03/03/2011 | US20110052502 MicroRNA Signatures Associated with Human Chronic Lymphocytic Leukemia (CCL) and Uses Thereof |
| 03/03/2011 | US20110052500 TAJ in Neuronal Function |
| 03/03/2011 | US20110052492 Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy |
| 03/03/2011 | US20110052490 Endoscopic mucosal resectioning using purified inverse thermosensitive polymers |
| 03/03/2011 | US20110052488 Methods For Treating, Diagnosing, and Monitoring Rheumatoid Arthritis |